IRVING KAUFMAN: Open Payments
NPI 1942341458 · SOMERSET, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$419 in 25 payments from 15 companies in 2025. Trend: 2023 $52 · 2024 $125 · 2025 $419
Food & beverage: $419
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $67 |
| Novo Nordisk Inc | 4 | $64 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| PFIZER INC. | 2 | $30 |
| Amgen Inc. | 2 | $29 |
| Medtronic, Inc. | 1 | $24 |
| Inspire Medical Systems, Inc. | 1 | $22 |
| Viatris Specialty LLC | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
Products named: UBRELVY, Wegovy, BREZTRI, Ozempic, OTEZLA, MINIMED 780G, INSPIRE, YUPELRI.
Industry payments across NJ — which companies pay providers there.
